Brief: Bone Biologics Regains Compliance With Nasdaq Continued Listing Requirements
26/06/2025 22:41
June 26 (Reuters) - Bone Biologics Corp BBLG.O: BONE BIOLOGICS REGAINS COMPLIANCE WITH NASDAQ CONTINUED LISTING REQUIREMENTS Source text: ID:nBw98kl7La Further company coverage: BBLG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bone Biologics
See all newsBone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview
Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months
Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview
Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview